Skip to main content

Table 2 Representing distribution of patients according to the period of hormonal therapy, symptomatic, endometrial thickness, and regularity by TVUS

From: Role of transvaginal ultrasound in detection of endometrial changes in breast cancer patients under hormonal therapy

 

No. = 50

Hormonal (year)

Mean ± SD

2.38 ± 1.42

Range

0.33–5

Symptomatic (vaginal bleeding)

No

41 (82.0%)

Yes

9 (18.0%)

US-endometrial thickness (mm)

Mean ± SD

10.22 ± 5.76

Range

3–30

US-endometrial regularity

Irregular

10 (20.0%)

Regular

40 (80%)